We are live on ! Find out more
DXTR

Dextera Surgical Inc.
DXTR

Delisted

DXTR was delisted on the 12th of December, 2017.

23 hedge funds and large institutions have $494K invested in Dextera Surgical Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

4% less funds holding

Funds holding: 2423 (-1)

48% less capital invested

Capital invested by funds: $941K → $494K (-$447K)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $43K

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
6
Closed
3
Calls
Puts
$43K
Net Calls
-$43K
Net Calls Change
-$43K

DXTR Hedge Fund Activity: Q3 2017 in Review

23 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Dextera Surgical Inc. (DXTR) for Q3 2017, worth a combined $494K — down 48% from $941K a quarter earlier.

Fund positioning in DXTR was balanced in Q3 2017: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 6 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $73.5K. The largest seller was Broadfin Capital, exiting entirely with an estimated $296K sold.

  • 23 institutional investors held Dextera Surgical Inc. (DXTR) as of Q3 2017, down from 24 in Q2 2017.
  • Funds reported $494K of Dextera Surgical Inc. stock for Q3 2017, down 48% quarter-over-quarter.
  • 3 funds opened new Dextera Surgical Inc. positions in Q3 2017 and 3 closed out, a net change of 0 holders.
  • The largest Dextera Surgical Inc. buyer in Q3 2017 was Virtu Financial, an estimated $73.5K added.
  • The largest Dextera Surgical Inc. seller in Q3 2017 was Broadfin Capital, an estimated $296K sold.

Based on aggregated 13F filings for Q3 2017.